期刊文献+

正交实验法优化超细硫酸沙丁胺醇的制备工艺 被引量:1

Optimization of process conditions for preparation ofsalbutamol sulfate ultrafine particles by orthogonal test
下载PDF
导出
摘要 以沙丁胺醇和硫酸为反应物 ,在异丙醇溶液中采用反应结晶法制备超细硫酸沙丁胺醇颗粒。通过正交实验 ,对制备过程中影响产物粒度和产率的因素 ,如 :硫酸浓度、反应温度、搅拌转速、反应时间等进行了系统研究并对优选条件进行了验证。实验结果表明 :当硫酸浓度为 1 0mol/L、反应温度为 5℃、搅拌转速为 90 0r/min、反应时间为 1 0min时 ,可以得到短轴为 5 0~ 6 0nm、长径比为 2 0~ 35且粒度分布较窄的针状硫酸沙丁胺醇颗粒。经IR、XRD分析表明 ,所得产品的纯度大于 98 0 % ,产率大于 95 0 % 。 It is well known that ultrafine salbutamol sulfate drug particles have higher bioavaibability than larger particles. A novel reactive precipitation process was used to prepare ultra fine salbutamol sulfate powders. In this work, salbutamol and sulphuric acids were used as reactants and isopropanol was used as a solvent. The effects of the concentration of sulphuric acid, reaction temperature, stirring speed and the reaction time on the particle size and the product yield of ultrafine salbutamol sulfate were investigated by orthogonal test. The ultrafine particles of salbutamol sulfate can be obtained and their particle sizes can be well controlled under following optimized conditions i.e. the sulphuric acid concentration of 1 0?mol/L, reaction temperature of 5?℃, stirring speed of 900?r/min and reaction time of 10?min. The particles are needle shaped, with mean short diameter of 50~60?nm, average aspect ratio of 20~35 and narrow particle size distribution. The product purity is more than 98% and its yield reaches 95 0%. All those characteristics were in accord with Chinese Pharmacopoeia (2002) and B. P. (1993). The operation of the experiment was very simple, and the particles were separated easily.
出处 《北京化工大学学报(自然科学版)》 CAS CSCD 2004年第3期1-3,8,共4页 Journal of Beijing University of Chemical Technology(Natural Science Edition)
基金 国家高技术" 86 3"研究发展计划项目(2 0 0 1AA2 1 80 6 1 ) 国家自然科学基金项目 (2 0 2 36 0 2 0 ) 中新国际合作项目 (S2 0 0 1 0 3)
关键词 硫酸沙丁胺醇 反应结晶法 超细颗粒 正交实验 salbutamol sulfate reactive precipitation ultra-fine particles orthogonal test
  • 相关文献

参考文献8

  • 1British pharmacopoeia commissin. British pharmacopoeia [M]. London: HMSO, 1993, 585, 1371, 1604
  • 2Weda M, Zanen P, De Boer A H. Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy[J]. Int J Pharm, 2002, 249(1 -2):247-255
  • 3Ashurst I C.Metered dose inhaler for albuterol[P].USA,6131566.2000-10-17
  • 4Esther B,NicholasI C,Robert S T,et al.A short synthesis of albuterol[J]. Synthesis, 1988, 2(13): 960
  • 5Reverchon E, Della Porta G, Pallado P. Supercritical antisolvent precipitation of salbutamol microparticles [J ].Powder Technol, 2001, 114 ( 1 - 3): 17 - 22
  • 6Michael R. Violanto, Harry W. Fishcher. Method for making uniformly sized particles form water-insoluble organic compounds[P]. USA, 4826689. 1989-05-02
  • 7陈芬儿,余红霞,万江陵,张珩,杨建设.硫酸沙丁胺醇的合成研究Ⅰ[J].中国药物化学杂志,1995,5(3):215-217. 被引量:10
  • 8秦红,何伍,罗宣德.沙丁胺醇合成路线图解[J].中国医药工业杂志,1997,28(4):189-190. 被引量:4

共引文献10

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部